Lympha Press® Global is a pioneering leader in providing dynamic compression therapy systems for the treatment of lymphedema, lipedema, and venous insufficiency. With over 40 years of experience, Lympha Press® has established itself as the leader in this niche segment of the Health Care industry, offering innovative and patented technology to improve patients' quality of life.
The company's commitment to research and development is evident through its range of products. The Lympha Press® Optimal Plus™ system, equipped with smart technology and advanced treatment sequences, demonstrates their dedication to technological advancement. Additionally, the Model 912 stands out as the most advanced and versatile 12-chamber dynamic compression system available, providing unparalleled efficacy in lymphedema treatment.
At the core of Lympha Press®'s ethos is the focus on patient well-being and comfort, highlighted by their patent-protected garments known for their high quality. Their global footprint and reputation are further substantiated by the presence of over 20 peer-reviewed publications endorsing the clinical effectiveness of their products.
Based in Israel, Lympha Press® continues to expand its reach, offering a full line of devices catering to both professional medical practitioners and those seeking at-home treatment solutions. The company's dedication to improving the lives of patients impacted by lymphatic and venous disorders positions it as an attractive prospect for potential investors and signifies significant potential for future growth and impact within the health care industry.
Contact: [email protected] | +972-77-9084-296
There is no investment information
No recent news or press coverage available for Lympha Press® Global.